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Objective To evaluate lipidomic differences between breast- and formula-fed infants.
Study design We utilized high-resolution mass-spectrometry methods to analyze 3.2 mm dried blood spot
samples collected at ages 3 months (n = 241) and 12 months (n = 144) from a representative birth cohort study.
Lipidomic profiles were compared between infants exclusively breast-fed, formula-fed, or mixed-fed, and related
to 12-month infancy weight. Data analysis included supervised multivariate statistics (partial least squares discrim-
inant analysis), and univariate analysis with correction for multiple testing.
Results Distinct differences in 3-month lipidomic profiles were observed between exclusively breast-fed and
formula-fed infants; mixed-fed infants showed intermediate profiles. Principle lipidomic characteristics of
breast-fed infants were lower total phosphatidylcholines (PCs), with specifically lower short chain unsaturated
PC but higher long chain polyunsaturated PC; higher cholesterol esters; and variable differences in sphingo-
myelins. At 12 months, lipidomic profiles were markedly different to those at 3 months, and differences be-
tween the earlier breast/formula/mixed-feeding groups were no longer evident. However, several specific
lipid species, associated with breast-feeding at 3 months, also correlated with differences in 3- to 12-month
weight.
Conclusions State-of-the-art dried blood spot sample lipidomic profiling demonstrated striking differences be-
tween breast-fed and formula-fed infants. Although these changes diminished with age, breast-fed lipidomic pro-
files at 3 months were associated with infancy weight and could potentially represent biomarkers of infant nutrition.
(J Pediatr 2015;166:276-81).
L
inks between early life exposures and later health outcomes may in part be due to nutritional programming in infancy.
This hypothesis is supported by observed long-term benefits associated with breast-feeding, such as better cognitive
development in childhood, and lower risks of obesity and high blood pressure in later life.1 Effects of early nutritional
interventions in infancy, using nutrient-enriched milk formulas, include increased later risk of metabolic disease.2 However, the
underlying mechanisms are unknown and are difficult to study.
Previous work has shown that the biochemical phenotype of infants differs according to feeding practice (breast- vs formula-
feeding). Higher total cholesterol levels,3-7 higher low density lipoproteins,5 and lower high density lipoproteins7 have been
reported in breast-fed infants, and may lead to lower cholesterol levels in adulthood.5,8,9 However, more detailed lipidomic
profiling in breast- vs formula-fed infants has not yet been performed. We, therefore, utilized technological developments
in lipidomics for metabolic phenotyping10 to obtain a detailed lipidomic profile from dried blood spot (DBS) samples in infants
recruited into the Cambridge Baby Growth Study (CBGS). Our aim was to investigate the relationships between infancy feeding
and age on specific lipids across multiple lipid classes.CBGS
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Table I. Demographics of infancy subgroups at 3 and
12 months of age
All 3 months
(N = 241),
mean ± SD
3-month
breast-fed
(N = 81),
mean ± SD
3-month
formula-fed
(N = 84),
mean ± SD
Sex (% male) 46% 42% 46%
Gestational age (wk) 39.9  1.5 40.2  1.3 39.8  1.5
Birth weight (kg) 3.50  0.52 3.54  0.43 3.50  0.57
3 m weight (kg) 6.13  0.80 5.96  0.66 6.38  0.76*
3 m weight SDS 0.07  1.05 0.19  0.88 0.25  0.96*
All 12 mo
(N = 141),
mean ± SD
12 mo initially
breast-fed
(N = 38),
mean ± SD
12 mo initially
formula-fed
(N = 50),
mean ± SD
Sex (% male) 55% 47% 56%
Gestational age (wk) 40.0  1.4 40.1  1.2 39.9  1.4
Birth weight (kg) 3.47  0.52 3.58  0.43 3.43  0.62
12 m weight (kg) 10.03  1.31 9.72  1.26 10.32  1.41*
12 m weight SDS 0.07  1.21 0.19  1.20 0.34  1.24*
*P < .05 between breast-fed and formula-fed infants.
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capillary heel prick sampling, dropping blood spots onto un-
treated filter paper cards (Ahlstrom 226; ID Biological Sys-
tems, Greenville, South Carolina). Infancy feeding
(exclusive breast-, mixed-, or exclusive formula-feeding)
was assessed by questionnaire at age 3 months. All children
were on a full mixed diet by 12 months of age. The study
was approved by the Cambridge local research ethics com-
mittee, and all mothers gave informed written consent.
DBS samples on filter paper cards were air dried at ambient
temperature overnight, before being stored in zip-loc storage
bags at 20C until analysis, when a single 3.2 mm spot was
punched from the larger DBS samples. Individuals with suf-
ficient DBS samples for multiple analyses were selected for
this nested study.
We recently reported that large-scale lipidomic profiling
platforms established for use on plasma samples10 can be suc-
cessfully adapted toDBS samples.12 In brief, a 3.2mmDBSwas
extracted in methanol in a well of a glass-coated 2.4 mL deep
well plate (Plate+TM; Esslab, Hadleigh, United Kingdom),
and lipidswere partitioned intomethyl tertiary butyl ether. Af-
ter centrifugation, the organic layer was concentrated and
used for lipid analysis. Samples were infused into a Thermo
Exactive benchtop orbitrap (Hemel; Hampstead, United
Kingdom), using an Advion Triversa Nanomate (Ithaca,
New York) and data acquired in both positive (1.2 kV voltage)
and negative modes (1.5 kV). All experiments were run with
blank controls and 2 different quality control samples. In total,
94 lipid species could be detected using this method.
Statistical Analyses
Lipidomic profiles were compared between infants exclusively
breast-fed, mixed-fed, and formula-fed, between age 3 vs
12months, and also related to infancyweight at age 12months.
The obtained lipid signals were semiquantitative, with the
signal intensity of each lipid expressed relative to the total lipid
signal intensity, for each individual, per thousand (&). Raw
high-resolution mass-spectrometry data were processed using
XCMS (www.bioconductor.org) and Peakpicker v 2.0 (an in-
house R script). All lipid species where >30% of cases had a
value of zero were excluded from further analyses; conse-
quently, 78 lipids were analyzed at 3 months, and 90 lipids
were compared between 3- and 12-month samples. Multivar-
iate analysis allowed analysis of multiple variables (all lipid
species) together, to avoid loss of information and to identify
underlying trends. These data were analyzed in SIMCA-P (v.
13; Umetrics AB, Umea, Sweden). Data were normalized using
log transformation and unit variance scaled. Principal compo-
nent analysis was used first to observe overall patterns and
detect outliers. Partial least squares-discriminant analysis
(PLS-DA) plots were then constructed, using Q2 values for
cross validation. The PLS-DA algorithm was chosen as this
maximizes separation between lipid variables for each categor-
ical outcome (infancy feeding/age), enabling clear determina-
tion of variables contributing to any separation. Receiver
operating characteristic curves were plotted to assess the pre-
dictive ability of obtained models (http://www.roccet.ca/).13Univariate analysis, using Mann-Whitney U for exclusively
breast-fed vs formula-fed infants, and Wilcoxon signed ranks
tests formatched age 3 vs 12month samples, was performed in
SPSS v 19 (SPSS Inc, Chicago, Illinois). A stringent Bonferroni
corrected P value (<.0006) was used to identify significant as-
sociations with individual lipids. This was calculated by
dividing the significance threshold of .05 by the number of var-
iables, in this case the lipids analyzed (78 at 3 months; 90
comparing 3 and 12 months). Spearman correlations were
used for correlations between DBS lipids and infancy weight.
Results
Twohundred forty-one infants (110male) hadDBS lipidomic
profilesmeasured at age 3months (mean SD: 97 9 days of
age); 141 infants (77male) at 12months (373 12 days), with
45 paired samples from the same infants at both time points.
The cohort characteristics are summarized in Table I, and the
sample was representative of the total CBGS (N = 1340 at
3 months), with mean  SD birth weight 3.49  0.55 kg, at
39.8  1.6 weeks gestation, 3-month weight 6.15  0.83 kg,
and 12-month weight 9.97  1.19 kg.
Infants transported the majority of long chain polyunsatu-
rated fatty acids (LC-PUFAs) as phospholipids, rather than as
cholesterol esters (CEs) or triglycerides (TGs). Overall in
these infant samples, phosphatidylcholines (PCs) contrib-
uted 35% of the total lipid signal; TGs in contrast only
contributed to approximately 10% of the total lipid signal.
DBS samples had been stored for 2.1-9.5 years at 20C.
Duration of storage was significantly positively correlated
with only 3 lipid species: lyso PC(18:0), PC(32:0), and
PC(34:3); none were inversely correlated. There was no sig-
nificant difference between the lipidomic profiles of male
and female infants, at either 3 or 12 months of age.
Of the 241 infants at 3 months of age, 81 were exclusively
breast-fed, 66 mixed-fed, and 84 formula-fed (4 infants277
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were excluded from further analysis). Table I shows the
marked anthropometric differences between exclusively
breast- and formula-fed infants, with higher weight in
formula-fed infants. In multivariate analysis, there was a
clear difference between the 3-month lipidomic profiles of
exclusively breast-fed vs exclusively formula-fed infants
(Q2 = 0.816; Figure 1), with mixed-fed infants showing an
intermediate profile (Q2 = 0.337; Figure 2; available at
www.jpeds.com).
Using univariate analysis, 30 individual lipid species
showed significant differences between exclusively breast-
fed and solely formula-fed infants (below the multicompari-
son corrected threshold: P < .0006) (Table II; available at
www.jpeds.com). Considering total levels of 3 main lipid
classes, the total PC level was lower in breast-fed compared
with formula-fed infants: mean values 350& vs 385&
(P < .0005), but there were no differences in total
sphingomyelins (SMs) or TGs.
Looking inmoredetail at these lipidomic profiles (Figure 3),
breast-fed infants had lower short chain unsaturated PCs but
higher longer chain polyunsaturated fatty acid containing
PCs. In addition, there were multiple individual differences
within the TG and SM lipid classes. Seven TGs were
significantly different between exclusively breast-fed and
formula-fed infants, with lower levels of polyunsaturated
fatty acid containing long chain TGs in the breast-fed infants.
There were several higher shorter chain SMs in the breast-fed
infants, but lower levels of many of the longer chain SMs.
Breast-fed infants had higher CE(16:0) and CE(20:4) levels.
Levels of 5 specific DBS lipids were sufficient to distinguish
between infant feeding patterns (exclusive breast-vs formula-
feeding) at an area under the receiver operating curve = 0.95
(95% CI: 0.879-0.997); these were PC(34:2) (lower in breast-
fed), SM(34:4) (lower in breast-fed) SM(36:1) (higher in
breast-fed), TG(50:1) (higher in breast-fed), and TG(51:2)
(higher in breast-fed).Figure 1. PLS-DA plot: 3-month lipids and nutrition (black: breas
278There were large differences between the lipidomic profiles
at 12months compared with 3months of age. In the 45 paired
DBS samples at both 3 and 12 months of age (Q2 = 0.916), 25
lipids showed significant age differences (P < .0006 with Wil-
coxon signed ranks tests) (Figure 4, B and Table III; available
at www.jpeds.com). These differences were also seen among
the larger number of unpaired samples at 3 and 12 months,
and additionally, when infants were separated into those
exclusively breast-fed for at least 3 months, and those
exclusively formula-fed, as shown in the multivariate
models (Q2 = 0.922; Figure 4, B and C).
Overall, there was a trend towards higher total PCs at age
12 months (377 vs 360, P = .06), but with variable differences
in specific PC species (Figure 5; available at www.jpeds.com).
PC class differences at 12 months, compared with 3 months,
included higher PC(34:2) containing palmitate, {with an
increased ratio of palmitate [PC(34:2)] to stearate
[PC(36:2)], P < .0005}, higher omega-3 containing PC 38:6
and lower omega-6 containing PC 38:4. Total CE (55 vs 45,
P < .0005) and specifically CE(18:2) was higher at
12 months, as were TGs, (127 vs 108, P = .04), particularly
long chain TGs (the majority polyunsaturated). Total SMs
was lower at 12 months (144 vs 164, P = .02).
Two DBS lipid signals were enough to predict age:
lyso PC(20:3) (higher at 12 months) and 1-alkyl,2-acylglycer-
ophosphocholine (PC-O) (34:1) [which cannot be dis-
tinguished from 1-(alkenyl),2-acylglycerophosphocholine
(PC-P) (34:0)12 (lower at 12 months)], creating a ro-
bust PLS-DA model with separation in 1 component
(Q2 = 0.791). Of note, the separation seen clearly between in-
fant feeding groups at 3 months was no longer apparent at
12 months of age (Q2 = 0.549; Figure 6).
Additional analyses of 3-month profiles investigated
correlations between those lipid species differing between
breast- and formula-fed infants, and 3-month, and 12-
monthweight SDS, as well as change in 3- to 12-monthweight
SDS. Infancy weight was positively associated with PC(34:1)t-fed; white: formula-fed).
Prentice et al
Figure 3. Levels of A, PCs; B, SMs; andC, TGs (median IQR) at 3 months of age in breast- and formula-fed infants. *P < .0006
(black: breast-fed; white: formula-fed).
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Figure 6. PLS-DAplot: 3- and 12-month DBS lipids (circles: 3months; triangles: 12months;black: breast-fed;white: formula-fed).
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PC-O(34:1) (rs 0.2, P = .003 at 3 months, rs 0.2, P = .009 at
12 months), and inversely associated with PC(38:4) (rs 0.2,
P < .0005 at 3 months, rs 0.2, P = .002 at 12 months)
(Table IV; available at www.jpeds.com), with no significant
association seen for the other lipid species that differed
between breast- and formula-fed infants. Although these
associations were no longer significantly related to 3- to 12-
month weight gain, 2 additional lipid species were inversely
associated with weight gain: SM(34:2) (rs 0.2, P = .005)
and PC-O(36:4) [which cannot be distinguished from PC-
P(36:3)12] (rs 0.2, P = .004) (Table IV; available at www.
jpeds.com).
Discussion
A wide variety of lipid classes contributed to the total lipido-
mic signal. We also demonstrate that, unlike adults, infants
transport LC-PUFAs mainly as phospholipids [eg,
PC(38:4), PC(38:6)], rather than as CEs and TGs.14 At
3 months, PCs contributed to 35% of the total lipid signal,
with the majority being medium and long chain-fatty acids.
However, it is also important to note that our study investi-
gated DBS samples, whereas most data in adults include only
serum or plasma circulating lipids. We observed no sex dif-
ferences, again differing with findings in later life.15,16
We found clear differences in lipidomic profiles by early
feeding pattern, with differences in specific lipids across all
main lipid classes between exclusively breast- and formula-
fed infants. Notably, formula and breast milk are not dissim-
ilar in their lipid composition, consisting primarily of
TGs,17,18 (with a larger diversity of fatty acids in the TGs of
breast milk19). Therefore, the infancy lipidomic profiles do
appear to not only reflect the lipid composition of the milk
intake, but also there may be additional effects of infant
nutrition on early fat metabolism.
The fatty acid composition of plasma and erythrocytemem-
branes lipids has been previously measured in children, using
gas chromatography, showing some fatty acid variation with280age, for example increasing linoleic acid and docosahexaenoic
acid from infancy to young adulthood.20 However, we show
that high-resolution mass-spectrometry provides a more
comprehensive overview of lipid metabolism. We demon-
strated very specific variation, including differences in the level
of saturation and carbon length for each lipid class, and adding
detail to overall total lipid class and fatty acid levels. For
example breast-fed, compared with formula-fed infants had
lower short chain unsaturated PC but higher LC-PUFA con-
taining PC. This extends previous but limited knowledge,
mainly focused on cholesterol and lipoprotein levels, into
breast and formula milk differences on early physiology and
metabolism. It is well documented that breast-fed infants
have higher total cholesterol3-7 and low-density lipoprotein
levels5 but lower high-density lipoprotein.7 We found higher
CEs CE(16:0) and CE(20:4) in breast-fed infants. Higher
omega 3- and 6-fatty acids in breast-fed infants have also
been reported.21 We found no difference in the omega-3 con-
taining PC 38:6, but showed higher omega-6 containing PC
38:4 levels in breast-fed infants.
What constitutes a favorable or “healthy” infancy lipido-
mic profile has yet to be established. However, lipid differ-
ences between exclusively breast- and formula-fed infants
may contribute to some of the benefits of breast milk intake,
including lower risk of infection, higher childhood cognitive
development, and lower obesity risk.1 For example, higher
proinflammatory lyso-PC levels in breast-fed infants could
potentially contribute to lower morbidity from infectious
disease.22 PC and SMs are both major contributors to cell
membrane structure. SMs particularly are essential for
specialized membrane formation in brain cells, signaling
pathways and the immune response,23 and SM intake has
previously been associated with improved neurodevelop-
ment in preterm infants.24
Previously reported changes in lipidomic profile with age
include CEs, and omega-3 and -6 PUFAs.25,26 We build on
this, showing changes in these lipid levels and other striking
differences across the whole lipidomic profile, with generally
lower SMs and higher TGs at 12 vs 3 months of age, againPrentice et al
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pilot work showed large PC differences, with increased
PC(34:2) containing palmitate at 12 months,12 and here we
confirm an increased palmitate:stearate at 12 months. We
also demonstrate that more PUFAs are transported as TGs,
with lower levels of PUFA-containing PC, than at 3 months
of age.
In agreement with previous small studies, which reported
that differences in cholesterol levels between breast- and
formula-fed infants attenuated after cessation of breast-
feeding and introduction of complementary foods,3,27 we
demonstrated no effect of infant milk feeding at 3 months
on lipidomic profile at 12 months. However, there may still
be long-term programming effects. We found strong trends
between 3 PCs at 3 months of age and infant weight at
both 3 and 12 months; 3-month PC(34:1) and PC-O(34:1)
were both positively related to infant weight and were also
lower in exclusively breast-fed infants. The omega 6 contain-
ing PC(38:4) was inversely associated with weight and was
also higher in exclusively breast-fed infants. These lipids
were not significantly associated with 3- to 12-month weight
gain and, therefore, are likely to reflect the maintenance of
the difference in weight between breast-fed and formula-
fed infants at 3-months. However, these PCs could still
have potential value as biomarkers linking infant nutrition
and growth. In addition, SM(34:2) and PC-O(36:4) were
inversely related to 3- to 12-month weight gain.
Further study should assess whether lipids might predict
ongoing weight gain and explore possible causal effects.
Use of lipid profiling in nutritional intervention studies
could also help to unravel these relationships and underlying
mechanisms. n
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Figure 2. PLS-DA plot: 3-month lipids and nutrition (black: breast-fed; white: formula-fed; gray: mixed-fed).
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Figure 4. A, PLS-DA plot: DBS lipids at 3 and 12months (45 paired samples, circles: 3 months; triangles: 12months).B,PLS-DA
plot: 3- and 12-month lipids in breast-fed infants (circles: 3 months; triangles: 12months).C, PLS-DA plot: 3- and 12-month lipids
in formula-fed infants (circles: 3 months; triangles: 12 months).
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Figure 5. Levels of lipid classes in paired samples at 3 and 12 months of age. A, TGs; B, SMs; and C, PCs (median  IQR).
*P < .0005.
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Table II. Lipid differences at 3 months of age between
exclusively breast-fed (N = 81) and exclusively formula-
fed (N = 84) infants (median [IQR]) per thousand (&)
Exclusively
breast-fed
(N = 81)
Exclusively
formula-fed
(N = 84)
Mixed-fed
(N = 66)
Total cholesterol 156 (42.0) 155 (29.6) 153 (46.0)
CEs
CE 16:0* 6.53 (3.04) 4.83 (2.6) 5.76 (2.08)
CE 18:1 14.3 (7.21) 16.3 (5.72) 15.9 (5.54)
CE 18:2 19.7 (7.94) 20.3 (6.76) 19.6 (8.28)
CE 20:4* 1.8 (1.01) 1.28 (1.1) 1.55 (0.998)
Phospholipids
PCs
PC 32:0 10.4 (4.73) 10.2 (3.37) 9.73 (4.69)
PC 34:1* 74.4 (17.7) 86.1 (14.6) 77.3 (17.0)
PC 34:2* 88.6 (22.9) 116 (20.9) 101 (20.4)
PC 34:3* 5.59 (1.42) 7.15 (1.94) 6.74 (1.90)
PC 35:2 2.65 (1.03) 2.94 (2.22) 2.45 (1.09)
PC 36:1 14.7 (2.88) 15.3 (2.86) 15.2 (3.82)
PC 36:2 72.5 (13.7) 75.2 (14.0) 72.6 (11.8)
PC 36:4 34.5 (7.56) 32.0 (7.28) 32.9 (6.72)
PC 37:4 0.847 (0.909) 0.110 (1.68) 0.630 (1.32)
PC 38:3* 7.26 (2.66) 5.19 (2.20) 6.33 (2.51)
PC 38:4* 20.9 (5.02) 16.4 (4.71) 19.0 (4.39)
PC 38:6 12.3 (3.27) 11.6 (2.58) 12.0 (4.09)
PC 40:7 3.79 (1.33) 3.03 (1.57) 3.58 (1.46)
Lyso-PC 18:0* 11.6 (3.56) 9.98 (3.29) 10.7 (4.0)
Lyso-PC 18:2 10.1 (3.99) 11.6 (3.48) 11.1 (4.92)
Lyso-PC 20:3 1.28 (0.741) 1.07 (0.784) 1.17 (0.633)
Lyso-PC 20:4 1.74 (0.702) 1.66 (0.559) 1.72 (0.662)
Lyso-PC 22:6 1.07 (0.956) 0.984 (1.04) 1.20 (1.06)
Lyso-PC-O 16:0 0.545 (1.01) 0.353 (0.874) 0.645 (0.966)
Lyso-PC-P 18:1 and
lyso-PC-O 18:2
0.836 (2.05) 0.451 (1.72) 0.560 (1.47)
PC-O 32:1 and
PC-P 32:0
3.02 (9.76) 1.80 (8.02) 2.10 (9.01)
PC-O 34:1 and
PC-P 34:0*
3.28 (1.05) 4.17 (1.20) 3.44 (1.37)
PC-O 34:3 and
PC-P 34:2
0.632 (0.495) 0.639 (0.484) 0.726 (0.458)
PC-O 38:5 and
PC-P 38:4*
2.12 (0.499) 1.89 (0.565) 1.94 (0.595)
PC-P 34:1 and
PC-O 34:2
1.20 (0.412) 1.32 (0.467) 1.27 (0.528)
PC-P 35:5* 1.49 (1.12) 0.594 (1.48) 1.32 (1.10)
PC-P 36:1 and
PC-O 36:2
1.29 (1.67) 0.573 (2.05) 1.11 (1.55)
PC-P 36:3 and
PC-O 36:4*
2.02 (0.674) 1.62 (0.459) 1.78 (0.489)
PC-P 36:4* 1.72 (0.415) 1.46 (0.492) 1.64 (0.536)
PC-P 38:3 and
PC-O 38:4
1.31 (0.502) 0.792 (1.18) 1.19 (0.593)
PEs
PE 36:3 1.32 (1.3) 1.11 (1.29) 1.41 (1.17)
PE 36:4 1.79 (2.39) 1.64 (1.77) 1.94 (2.47)
PE 40:2 2.24 (9.3) 1.51 (6.75) 2.73 (12.8)
Mixed PC and PE
PC 33:1 and PE 36:1 4.29 (2.32) 1.69 (4.7) 4.27 (2.71)
PC 33:2 and PE 36:2 1.16 (0.754) 1.21 (0.729) 1.20 (0.635)
PC 35:1 and PE 38:1 4.97 (2.57) 2.51 (9.03) 5.26 (6.15)
PC 35:4 and PE 38:4 1.21 (0.888) 1.01 (0.87) 1.24 (0.725)
SMs
SM 33:1 2.16 (1.39) 2.27 (1.27) 2.39 (1.44)
SM 34:1 51.1 (21.9) 46.6 (13.4) 48.9 (21.7)
SM 34:2* 4.55 (1.49) 3.60 (1.16) 4.23 (1.34)
SM 34:4* 2.10 (1.33) 3.23 (1.76) 2.63 (1.49)
SM 36:0* 1.55 (0.476) 1.09 (0.894) 1.44 (0.71)
SM 36:1* 11.2 (3.61) 8.99 (2.6) 10 (2.68)
SM 37:1 1.72 (1.14) 1.30 (1.52) 1.61 (1.31)
SM 38:1* 7.09 (1.71) 9.88 (3.01) 7.94 (2.31)
(continued )
Table II. Continued
Exclusively
breast-fed
(N = 81)
Exclusively
formula-fed
(N = 84)
Mixed-fed
(N = 66)
SM 39:1* 1.92 (0.446) 3.48 (1.62) 2.42 (0.842)
SM 40:1* 10.3 (3.97) 12.3 (3.52) 11.2 (3.09)
SM 40:2* 6.38 (2.13) 7.61 (2.57) 6.71 (2.51)
SM 40:3 1.23 (9.27) 0.577 (10.6) 1.04 (11.7)
SM 41:1* 2.91 (0.98) 3.61 (1.01) 3.21 (0.663)
SM 41:2 2.95 (1.37) 2.82 (1.04) 2.82 (1.87)
SM 42:1 9.08 (4.26) 9.37 (4.51) 9.68 (4.02)
SM 42:2 24.8 (8.38) 24.1 (8.47) 24.5 (9.19)
SM 42:3* 9.49 (2.79) 6.57 (8.43) 7.60 (9.56)
SM 42:4 2.08 (1.00) 2.18 (0.95) 2.11 (0.725)
TGs
TG 44:0 1.52 (2.21) 1.62 (1.76) 1.91 (2.16)
TG 44:1 0.813 (2.13) 1.07 (1.5) 1.39 (1.99)
TG 46:1* 2.20 (1.39) 3.01 (2.23) 2.22 (1.81)
TG 46:2 1.04 (1.49) 1.31 (1.37) 1.36 (1.83)
TG 48:1 4.02 (2.49) 3.00 (1.87) 3.28 (1.92)
TG 48:2* 2.33 (1.4) 3.48 (2.25) 2.45 (1.80)
TG 48:3 1.04 (7.07) 3.28 (5.22) 2.13 (10.4)
TG 50:1* 10.2 (5.44) 8.05 (4.13) 8.92 (4.94)
TG 50:2 8.17 (4.32) 7.23 (3.96) 7.68 (3.48)
TG 50:3 2.09 (1.07) 2.00 (1.13) 1.95 (0.915)
TG 51:2* 1.12 (0.679) 0.170 (0.965) 0.994 (0.936)
TG 52:2 25.8 (11.9) 28.8 (11.3) 26.1 (11.4)
TG 52:3 12.4 (4.65) 13.5 (6.14) 12.0 (4.93)
TG 52:4 2.63 (1.29) 2.83 (1.53) 2.46 (1.14)
TG 54:3* 6.84 (3.35) 10.8 (5.01) 7.42 (5.05)
TG 54:4* 3.07 (1.67) 4.80 (2.62) 3.20 (2.29)
TG 54:5* 1.08 (0.606) 1.44 (0.821) 1.13 (0.598)
TG 54:6 0.637 (0.806) 0.39 (0.668) 0.464 (0.904)
PE, phosphoethanolamine.
Each fatty acid number corresponds to the number of carbon atoms: number of double bonds in
the fatty acid.
*P < .0006 (between breast-fed and formula-fed infants).
February 2015 ORIGINAL ARTICLES
Lipidomic Analyses, Breast- and Formula-Feeding, and Growth in Infants 281.e4
Table III. Lipid differences between paired samples at
3months and 12months of age (N = 45) (median [IQR])
per thousand (&)
3-mo, median
(IQR), N = 45
12-mo, median
(IQR), N = 45
Total cholesterol 154 (50.7) 169 (29.4)
CEs
CE 16:0 5.80 (3.56) 6.04 (1.07)
CE 16:1 0.684 (2.37) 1.80 (0.965)
CE 18:1 16.6 (7.03) 15.9 (3.49)
CE 18:2* 19.6 (7.14) 28.8 (9.71)
CE 20:4 1.39 (1.09) 1.82 (1.22)
Phospholipids
PCs
PC 32:0* 9.64 (3.13) 7.48 (1.92)
PC 34:3 6.22 (2.26) 6.14 (1.41)
PC 34:1 76.2 (21.4) 75.5 (14.4)
PC 34:2* 98.5 (31.7) 130 (21.4)
PC 35:2 2.60 (1.13) 2.81 (0.96)
PC 36:1 15.2 (4.17) 11.6 (5.01)
PC 36:2 72.0 (14.7) 66.6 (10.4)
PC 36:4 35.3 (7.45) 34.6 (9.35)
PC 38:3* 6.70 (2.98) 4.51 (1.59)
PC 38:4* 19.5 (4.16) 16.3 (5.53)
PC 38:6* 12.0 (2.61) 16.2 (8.16)
Lyso-PC 16:0* 21.5 (5.89) 16.7 (4.95)
Lyso-PC 16:1 0.182 (1.71) 0.756 (0.637)
Lyso-PC 17:0 0.163 (0.917) 0.557 (0.303)
Lyso-PC 18:0* 10.3 (3.19) 7.16 (2.23)
Lyso-PC 18:1* 7.02 (2.82) 4.24 (1.4)
Lyso-PC 18:2* 10.6 (4.27) 6.45 (2.57)
Lyso-PC 20:3* 1.37 (0.636) 15.6 (12.8)
Lyso-PC 20:4* 1.75 (0.616) 1.24 (0.406)
Lyso-PC 22:6 1.01 (1.40) 0.714 (0.257)
Lyso-PC-O 16:0 0.297 (1.07) 0.502 (0.142)
PC-O 32:1 and PC-P 32:0 3.02 (5.88) 3.40 (2.22)
PC-O 34:1 and PC-P 34:0* 3.43 (1.27) 1.46 (0.298)
PC-O 34:3 and PC-P 34:2* 0.606 (0.521) 1.10 (0.256)
PC-O 38:5 and PC-P 38:4 2.18 (0.593) 2.57 (0.71)
PC-P 34:1 and PC-O 34:2 1.29 (0.499) 1.3 (0.402)
PC-P 35:5 1.09 (1.62) 0.694 (0.334)
PC-P 36:1 and PC-O 36:2 0.605 (1.69) 1.64 (0.812)
PC-P 36:3 and PC-O 36:4* 2.03 (0.646) 2.38 (0.997)
PC-P 36:4 1.64 (0.417) 1.84 (0.809)
PC-P 38:3 and PC-O 38:4 1.20 (0.800) 1.25 (0.37)
PEs
PE 36:3 1.04 (1.20) 0.684 (0.163)
PE 36:4 1.67 (1.94) 0.984 (0.386)
PE 40:2 2.47 (7.26) 3.86 (1.38)
Mixed PCs and PEs
PC 33:1 and PE 36:1* 3.48 (3.72) 1.12 (0.306)
PC 33:2 and PE 36:2 1.11 (0.68) 1.20 (0.47)
PC 35:1 and PE 38:1 4.23 (3.05) 2.05 (2.04)
PC 35:3 and PE 38:3 0.192 (1.32) 1.07 (0.848)
PC 35:4 and PE 38:4 1.11 (0.681) 1.07 (0.203)
PE 40:5 and PC 37:5 0.39 (1.96) 1.25 (0.548)
SMs
SM 33:1 2.17 (1.37) 1.64 (0.686)
SM 34:1 48.4 (24.9) 42.9 (13.5)
SM 34:2 4.10 (1.50) 3.95 (1.17)
SM 34:4 2.51 (2.00) 1.79 (1.78)
SM 36:0 1.36 (0.779) 0.892 (0.184)
SM 36:1* 10.0 (3.95) 7.64 (2.61)
SM 36:2 0.00 (4.88) 1.82 (0.662)
SM 37:1 1.55 (1.24) 0.751 (0.591)
SM 38:1* 7.73 (2.56) 5.04 (0.992)
SM 39:1* 2.27 (1.18) 1.48 (0.549)
SM 40:1 11.6 (3.76) 10.8 (2.83)
SM 40:2 6.94 (2.52) 5.64 (1.54)
SM 40:3 0.824 (8.00) 5.52 (2.49)
SM 41:1* 3.32 (0.993) 4.34 (1.20)
(continued )
Table III. Continued
3-mo, median
(IQR), N = 45
12-mo, median
(IQR), N = 45
SM 41:2 2.83 (1.63) 2.07 (0.611)
SM 42:1 8.84 (4.59) 9.77 (3.67)
SM 42:2 24.4 (8.90) 22.8 (5.85)
SM 42:3 7.27 (10.5) 5.93 (1.67)
SM 42:4 2.27 (1.15) 2.00 (0.864)
TGs
TG 44:0 1.38 (2.28) 1.02 (0.457)
TG 44:1 1.32 (1.99) 0.928 (0.836)
TG 46:1 2.19 (2.51) 1.68 (1.94)
TG 46:2 1.24 (1.58) 0.879 (0.619)
TG 48:1 3.81 (2.14) 5.29 (3.97)
TG 48:2 2.31 (2.27) 2.85 (2.33)
TG 48:3 2.13 (8.55) 1.79 (1.35)
TG 49:1 0.317 (1.66) 1.07 (0.739)
TG 50:1 9.44 (4.42) 13.3 (8.4)
TG 50:2* 8.16 (4.05) 11.6 (6.95)
TG 50:3 2.04 (1.21) 2.78 (1.41)
TG 50:4 0.00 (3.37) 1.08 (0.782)
TG 51:1 0.283 (1.59) 0.933 (0.345)
TG 51:2* 0.673 (1.12) 1.36 (0.681)
TG 52:2 26.9 (11.8) 32.9 (17.0)
TG 52:3* 12.6 (4.46) 17.3 (8.01)
TG 52:4* 2.84 (1.31) 4.17 (2.91)
TG 52:5* 0.00 (0.969) 0.856 (0.200)
TG 53:2 0.684 (2.83) 1.63 (0.953)
TG 54:3 7.57 (6.52) 7.45 (5.33)
TG 54:4 3.49 (2.48) 4.11 (3.38)
TG 54:5 1.11 (0.559) 1.80 (1.12)
*P < .0006.
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Table IV. Associations between 3-month lipid and
infancy weight
Lipid
3-mo
weight SDS
12-mo
weight SDS
3- to 12-mo
weight gain SDS
Spearman
P
value Spearman
P
value Spearman
P
value
PC-O 34:1* 0.2 .003 0.2 .009 0.03 .7
PC 34:1* 0.2 <.0005 0.2 .003 0.01 .9
PC 38:4† 0.2 <.0005 0.2 .002 0.04 .6
SM 34:2† 0.06 .4 0.07 .3 0.2 .005
PC-O 36:4† 0.1 .1 0.2 .02 0.2 .004
*Lower values in exclusively breast-fed.
†Higher values in exclusively breast-fed.
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